Financial Performance - The company's gross profit margin decreased by 3.77% due to a significant decline in sales prices, despite an increase in production and sales scale compared to the previous year[3]. - In the first three quarters of 2023, the basic chemical industry achieved a total revenue of 1,855.7 billion yuan, a year-on-year decrease of 4.64%, and a net profit attributable to shareholders of 109.0 billion yuan, down 49.61% year-on-year[3]. - The company's operating revenue for 2023 was ¥658,214,081.40, a decrease of 11.35% compared to ¥742,465,457.59 in 2022[30]. - The net profit attributable to shareholders for 2023 was ¥14,733,064.67, down 75.96% from ¥61,274,503.04 in the previous year[30]. - The net profit after deducting non-recurring gains and losses was ¥12,022,861.12, a decline of 77.20% from ¥52,741,320.76 in 2022[30]. - The net cash flow from operating activities decreased by 49.42% to ¥82,635,703.18 from ¥163,360,835.84 in 2022[30]. - Basic earnings per share for 2023 were ¥0.0267, down 75.97% from ¥0.1111 in 2022[30]. - The total profit for the year was CNY 13.43 million, down 79.08% year-on-year[55]. - The company reported a significant decrease in both net profit and cash flow, raising concerns about its ongoing operational stability[30]. - The company has faced challenges in maintaining profitability, as indicated by the substantial drop in net profit and earnings per share[30]. Investment and R&D - The company plans to increase R&D investment to enhance product competitiveness and optimize product structure through technological advancements[6]. - Research and development investment reached ¥35,149,300, accounting for 5.34% of operating revenue, indicating a commitment to innovation[59]. - The company has developed a "one chain three bodies" business structure, focusing on various intermediate products, including pharmaceutical and agricultural intermediates[53]. - The company has established a stable and efficient R&D innovation system, ensuring its competitive advantage in production processes[60]. - The company is focusing on upgrading and optimizing processes such as sulfonation and hydrogenation to enhance competitiveness in line with national policies promoting environmentally friendly technologies[43]. Market and Sales - The retail sales of cosmetics in China reached 414.2 billion yuan in 2023, growing by 5.1% year-on-year, which may positively impact the demand for dye and daily chemical intermediates[42]. - The company aims to expand its market presence by leveraging its leading position in the intermediate production chain and optimizing its product offerings[40]. - The company maintains a high market share for its main products, despite facing increased competition and declining sales prices in some sub-industries[47]. - Domestic sales increased by 27.06% to ¥420,244,767.84, while foreign sales decreased by 42.20% to ¥237,969,313.56[63]. - The sales of dye and daily chemical intermediates increased by 12.33% to ¥296,676,976.08, while the sales of pharmaceutical and pesticide intermediates decreased by 35.02%[63]. Environmental and Safety Management - The company will continue to invest in environmental protection measures to comply with stricter regulations and enhance its overall environmental awareness[9]. - The company has implemented a comprehensive environmental monitoring plan, including pollutant types, detection frequency, and emission limits, approved by the Cangzhou Administrative Approval Bureau[167]. - The company has achieved compliance with emission standards, with total emissions of SO2 at 9.225t/a and NOx at 29.35943t/a, both within regulatory limits[164]. - The company has maintained a zero major safety production accident record during the reporting period, reflecting effective safety management practices[171]. - The company has conducted 2 comprehensive safety drills and 25 on-site response drills, enhancing emergency preparedness and response capabilities[171]. Corporate Governance - The company has established a performance evaluation and incentive system linking management compensation to business performance[110]. - The governance structure complies with relevant laws and regulations, ensuring equal rights for all shareholders and maintaining operational independence from the controlling shareholder[108]. - The company has a robust governance structure with independent boards and committees, adhering to legal requirements and operational independence[113]. - The company has established an independent financial department with a dedicated accounting system, ensuring independent financial decision-making and tax compliance[113]. - The company has a clear strategy for market expansion and product development, although specific figures and timelines were not disclosed in the provided content[112]. Talent and Human Resources - The company emphasizes the importance of attracting and nurturing high-quality technical and management talent to mitigate risks associated with talent shortages[7]. - The total number of employees at the end of the reporting period is 886, with 684 in production, 103 in technical roles, and 73 in administrative positions[141]. - The company has established a comprehensive training system, conducting at least four safety training sessions annually for middle management and above[144]. - The company has implemented a stock option and restricted stock incentive plan, granting 7,258,000 stock options and 8,195,000 restricted shares to 101 incentive recipients[150]. - The company has a talent strategy focusing on employee rights and welfare, including competitive benefits and regular professional training[173]. Future Outlook and Strategy - The company is committed to a long-term strategy of expanding production scale and optimizing management systems to reduce production costs and improve risk resistance in changing market conditions[101]. - The company plans to increase investment in new product development and process optimization, aiming to shorten the product development cycle[104]. - The company is focused on integrating into the Beijing-Tianjin-Hebei collaborative development strategy and capitalizing on opportunities from "China Manufacturing 2025" and "carbon peak and carbon neutrality" initiatives[100]. - The company is positioned to adapt to the uncertainties of the economic environment by enhancing its existing product market positioning and expanding sales channels[101]. - The company is actively engaged in new product research and development to create new industrial chains and increase profitability[101].

证券代码：300107 证券简称：建新股份 公告编号：2024-009 河北建新化工股份有限公司 第六届监事会第五次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下称"公司"）第六届监事会第五次会议于 2024 年 4 月 23 日在公司八楼会议室以现场方式召开。会议通知于 2024 年 4 月 13 日以书面及通讯的方式发出，本次会议应出席监事 3 人，实际出席监事 3 人， 会议由公司监事孙维政先生主持。公司全体董事、高级管理人员列席了会议。本 次会议的召集、召开、表决程序符合《中华人民共和国公司法》和《公司章程》 的规定。会议经全体监事表决，通过以下事项： 一、审议通过《关于<公司 2023 年度监事会工作报告>的议案》 《公司 2023 年度监事会工作报告》详见中国证监会指定的创业板上市公司 信息披露网站巨潮资讯网(www.cninfo.com.cn)的公告。 表决结果：同意 3 票，反对 0 票，弃权 0 票，获得通过。 本议案尚需提交公司 2023 年年度股东大会审议通过。 二、审议通过《关于<公司 20 ...

河北建新化工股份有限公司章程 河北建新化工股份有限公司 章程 二〇二四年四月 1 | 第一章 | 总 | 则 3 | | --- | --- | --- | | 第二章 | | 经营宗旨和经营范围 4 | | 第三章 | | 股份 5 | | 第一节 | | 股份发行 5 | | 第二节 | | 股份增减和回购 6 | | 第三节 | | 股份转让 7 | | 第四章 | | 股东和股东大会 8 | | 第一节 | | 股东 8 | | 第二节 | | 股东大会的一般规定 11 | | 第三节 | | 股东大会的召集 错误!未定义书签。 | | 第四节 | | 股东大会的提案与通知 错误!未定义书签。 | | 第五节 | | 股东大会的召开 错误!未定义书签。 | | 第六节 | | 股东大会的表决和决议 2 错误!未定义书签。 | | 第五章 | | 董事会 错误!未定义书签。 | | 第一节 | | 董 事 错误!未定义书签。 | | 第二节 | | 董事会 30 | | 第六章 | | 总经理及其他高级管理人员 错误!未定义书签。 | | 第一节 | | 总经理及其他高级管理人员 错误!未定义书签。 | ...

河北建新化工股份有限公司 独立董事 2023 年度述职报告 （张兰丁） 各位股东及股东代表： 本人作为河北建新化工股份有限公司（以下简称"公司"）的独立董事，在 2023 年度严格按照《公司法》、《证券法》、《上市公司独立董事管理办法》、 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等法律法规、规范性文件以及《公司章程》、《独立董事工作细则》等相关规定 和要求，在 2023 年度任期工作中，诚实、勤勉、独立地履行职责，及时了解公 司的生产经营信息，全面关注公司的发展状况；积极出席相关会议，认真审议董 事会各项议案并发表了独立客观的意见，维护了公司整体利益，维护了全体股东 特别是中小股东的合法权益。现将 2023 年度履职情况述职如下： 一、本人基本情况 （一）工作履历、专业背景及兼职情况 本人张兰丁，1971 年出生，中国国籍，无永久境外居留权，硕士。2010 年 4 月至今在矽亚股权投资基金管理（上海）有限公司任 CEO。现任建新股份、飞 科电器、中颖电子独立董事。2023 年 5 月至今任公司独立董事。 （二）不存在影响独立性的情况 2023 年度，本人对独立性情况进行了自 ...

河北建新化工股份有限公司 审 计 报 告 众环审字(2024)2700352号 目 录 审计报告 | 财务报表 | | | --- | --- | | 合并资产负债表 | 1 | | 合并利润表 | 3 | | 合并现金流量表 | 4 | | 合并股东权益变动表 | 5 | | 资产负债表 | 7 | | 利润表 | 9 | | 现金流量表 | 10 | | 股东权益变动表 | 11 | | 财务报表附注 | 13 | 起始页码 审 计 报 告 众环审字(2024)2700352 号 河北建新化工股份有限公司全体股东： 一、 审计意见 我们审计了河北建新化工股份有限公司（以下简称"河北建新化工公司"）财务报表， 包括 2023 年 12 月 31 日的合并及公司资产负债表，2023 年度的合并及公司利润表、合并及 公司现金流量表、合并及公司股东权益变动表以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制，公允反映了 河北建新化工公司 2023 年 12 月 31 日合并及公司的财务状况以及 2023 年度合并及公司的经 营成果和现金流量。 二、 形成审计意见的基础 我们按 ...

河北建新化工股份有限公司 内部控制鉴证报告 众环专字（2024）2700114号 目 录 起始页码 鉴证报告 说明 内部控制有关事项的说明 1 内部控制鉴证报告 众环专字（2024）2700114 号 河北建新化工股份有限公司全体股东： 我们接受委托，审核了河北建新化工股份有限公司（以下简称"河北建新化工公司"） 管理层对 2023 年 12 月 31 日与财务报表相关的内部控制有效性的认定。按照《企业内部控 制基本规范》、《企业内部控制应用指引》、《企业内部控制评价指引》的规定，建立健全和有 效实施内部控制，并评价其有效性是河北建新化工公司管理层的责任。我们的责任是对河北 建新化工公司截至 2023 年 12 月 31 日止与财务报表相关的内部控制的有效性发表鉴证意见。 我们按照《中国注册会计师其他鉴证业务准则第3101号——历史财务信息审计或审阅以 外的鉴证业务》并参照《内部控制审核指导意见》的规定执行了鉴证业务。上述规定要求我 们计划和执行鉴证工作，以对鉴证对象信息是否不存在重大错报获取合理保证。在鉴证过程 中，我们实施了包括了解、测试和评价内部控制系统的建立和实施情况，以及我们认为必要 的其他程序。我 ...

证券代码：300107 证券简称：建新股份 公告编号：2024-0013 河北建新化工股份有限公司 关于 2023 年度利润分配预案的公告 河北建新化工股份有限公司（以下简称"公司"）于 2024 年 4 月 23 日召开 了第六届董事会第六次会议、第六届监事会第五次会议，审议通过了《关于公司 2023 年度利润分配的预案》。现将相关情况公告如下： 一、2023 年度利润分配预案基本情况 经中审众环会计师事务所（特殊普通合伙）审计，2023 年度母公司实现净 利润 18,795,017.16 元。根据《公司法》和《公司章程》等其他相关规定，按 2023 年度公司净利润的 10%提取法定盈余公积金 1,879,501.72 元，余下未分配 利润 16,915,515.44 元，加上年结转未分配利润 544,059,913.10 元，扣除 2022 年度权益分派 33,103,864.08 元 ， 2023 年度可供 股 东 分配的利润为 527,871,564.46 元。 在符合利润分配原则、保证公司正常经营和长远发展的前提下，为持续回报 股东，与全体股东共同分享公司发展的经营成果，根据《公司法》、《公司章程》 ...

为充分尊重投资者、提升交流的针对性，现就公司 2023 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2024 年 4 月 29 日（星期一）15:00 前访问 https://ir.p5w.net/zj/，或扫描下方二维 码，进入问题征集专题页面。公司将在 2023 年度业绩说明会上，对投资者普遍 关注的问题进行回答。 欢迎广大投资者积极参与本次网上说明会。 证劵代码：300107 证劵简称：建新股份 公告编号：2024-019 河北建新化工股份有限公司 关于举行2023年度业绩网上说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）定于 2024 年 4 月 30 日（星 期二）15:00-17:00 在全景网举办 2023 年度业绩说明会，本次年度业绩说明会 将采用网络远程的方式举行，投资者可登陆全景网"投资者关系互动平台" （https://ir.p5w.net）参与本次年度业绩说明会。 出席本次年度业绩说明会的人员有：公司董事长朱守琛先生、总经理兼董事 会秘书陈 ...

证券代码：300107 证券简称：建新股份 公告编号：2024-015 河北建新化工股份有限公司 （一）机构信息 1、基本信息 （1）机构名称：中审众环会计师事务所（特殊普通合伙） （2）成立日期：中审众环始创于1987年，是全国首批取得国家批准具有从 事证券、期货相关业务资格及金融业务审计资格的大型会计师事务所之一。根据 财政部、证监会发布的从事证券服务业务会计师事务所备案名单，本所具备股份 有限公司发行股份、债券审计机构的资格。2013年11月，按照国家财政部等有关 要求转制为特殊普通合伙制。 （3）组织形式：特殊普通合伙企业 （4）注册地址：湖北省武汉市武昌区水果湖街道中北路166号长江产业大厦 17-18层。 关于拟续聘会计师事务所的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下称"公司"）于2024年4月23日召开了第 六届董事会第六次会议、第六届监事会第五次会议，审议通过了《关于拟续聘会 计师事务所的议案》，同意拟继续聘任中审众环会计师事务所（特殊普通合伙） 为公司2024年度审计机构，该议案尚需提交公司202 ...

Financial Performance - The company's revenue for Q1 2024 was CNY 154,032,546.54, representing a 21.77% increase compared to CNY 126,497,669.98 in the same period last year[5] - Net profit attributable to shareholders reached CNY 8,128,490.67, a significant increase of 124.95% from CNY 3,613,439.28 year-on-year[5] - The total profit for Q1 2024 was CNY 8,611,700.86, reflecting a 147.19% increase from CNY 3,483,848.75 in the same period last year[9] - Operating profit for Q1 2024 was ¥8,761,744.24, up from ¥3,633,773.65 in the same period last year, representing a growth of 141.5%[20] - Net profit attributable to the parent company for Q1 2024 was ¥8,128,490.67, compared to ¥3,613,439.28 in Q1 2023, marking a year-over-year increase of 125.5%[20] - Basic and diluted earnings per share for Q1 2024 were both ¥0.0147, compared to ¥0.0065 in Q1 2023, indicating a significant improvement[20] Cash Flow - The net cash flow from operating activities surged to CNY 71,614,959.53, marking a 622.10% increase compared to CNY 9,917,607.93 in Q1 2023[9] - Operating cash inflow for the current period reached ¥187,616,318.35, a significant increase of 69.8% compared to ¥110,587,295.41 in the previous period[23] - Net cash flow from operating activities amounted to ¥71,614,959.53, up from ¥9,917,607.93, reflecting a substantial growth[23] - Cash outflow from investment activities totaled ¥56,557,767.02, compared to ¥49,509,997.50 in the previous period, indicating increased investment efforts[23] - Net cash flow from investment activities was -¥47,249,515.49, worsening from -¥29,008,163.17 in the previous period[23] - Cash flow from financing activities showed a net inflow of ¥408,486.20, with no outflows reported[24] - The net increase in cash and cash equivalents for the period was ¥25,825,783.05, recovering from a decrease of -¥19,743,992.77 in the previous period[24] - The ending balance of cash and cash equivalents stood at ¥398,300,541.93, up from ¥333,316,261.82 at the end of the previous period[24] Assets and Liabilities - Total assets at the end of Q1 2024 were CNY 1,681,171,157.09, a slight increase of 0.66% from CNY 1,670,120,180.70 at the end of the previous year[5] - Total current assets reached RMB 846,162,035.68, slightly up from RMB 842,643,909.59 at the beginning of the period[16] - Fixed assets increased to RMB 539,065,807.56 from RMB 505,546,285.19[16] - Total liabilities decreased to ¥201,810,587.96 in Q1 2024 from ¥203,392,726.89 in Q1 2023, a reduction of 0.8%[18] - The total equity attributable to shareholders increased to ¥1,479,360,569.13 in Q1 2024, compared to ¥1,466,727,453.81 in Q1 2023, an increase of 0.9%[18] Research and Development - Research and development expenses increased by 26.87% to CNY 8,289,461.85, compared to CNY 6,533,821.95 in Q1 2023, indicating a focus on innovation[8] - Research and development expenses increased to ¥8,289,461.85 in Q1 2024, up from ¥6,533,821.95 in Q1 2023, reflecting a growth of 26.9%[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 45,102[11] - The largest shareholder, Zhu Shouchan, holds 38.78% of shares, totaling 215,768,643 shares[11] Investments and Agreements - The company invested RMB 2.96 million for an 18.5% stake in Hebei Jianxin Flying Car Technology Co., Ltd[13] - A cooperation agreement was signed with Klein Vision for the exclusive rights to produce and sell flying cars in China, with a contract value of €2 million[13] Financial Management - The company reported a decrease in financial expenses by 155.79%, resulting in a net financial income of CNY -4,358,311.83, compared to CNY -1,703,866.80 in Q1 2023[8] - The company received government subsidies amounting to CNY 765,900.00, contributing to its financial performance in the quarter[6] Risk Management - The company is monitoring risks associated with its investment in the flying car sector, including market acceptance and regulatory challenges[14] Accounting Standards - The company has not undergone an audit for the first quarter report[25] - The company is implementing new accounting standards starting from 2024, which may affect future financial reporting[25]